Skip to main content
Announcement

January 30, 2026

Statement from Libby Jones, Associate Vice President, Global Health Advocacy Incubator, Overdose Prevention Initiative in response to “White House Great American Recovery Initiative”

“The Administration’s launch of the Great American Recovery Initiative arrives as CDC data show U.S. life expectancy rose to 79.0 years in 2024, linked in part to fewer overdose deaths. That progress proves something simple. When leaders fund and implement evidence-based strategies at scale, more people live. 

The most important test will be whether it strengthens the systems that are already working.  

Recent declines in overdose deaths demonstrate that targeted prevention and treatment strategies can deliver results when they are implemented consistently and at scale. These gains were not accidental. They reflect deliberate investments in evidence-based care and recovery supports. Sustaining and building on this progress will require protecting uninterrupted care and ensuring that people can access treatment when they are ready. 

Rather than creating a new coordinating effort that never reaches the street, I encourage the Administration and Congress to fully fund and appropriately staff the agencies and programs that helped reduce overdose deaths. This announcement should translate into funded programs, staffed agencies and clear outcomes. 

A coordinated federal approach can help communities move faster and save more lives, but only if it expands access to evidence-based care and protects continuity of care. People cannot recover if they cannot get timely treatment and support, and they cannot stay in recovery if coverage and services drop at the moments of highest risk, especially after a nonfatal overdose or following release from jail or prison. 

We urge federal agencies to use this initiative to scale what works: medications for opioid use disorder, naloxone access and recovery support services that keep people connected to care. Research shows buprenorphine and methadone reduce overdose death risk, yet too many people still cannot access them when they are ready.  

We stand ready to support implementation that delivers measurable results, fewer overdoses, faster treatment initiation and stronger follow through into care in every community.” 

Related News

View All News

August 31, 2026

Declining Overdose Deaths Are Not a Signal to Retreat

Every International Overdose Awareness Day, communities around the world come together to remember the people who died from overdose, support the families, friends and communities living with that loss, and take action to prevent future deaths. 

In my work, I have seen firsthand what is possible when people can access the support they need and what happens when those supports are out of reach. 

Remembrance matters. But remembrance alone will not prevent the next overdose. 

August 3, 2026

Congress Comes Home in August. Here Is How to Meet Them There.

Congress will spend much of August closer to home while fiscal year 2027 funding remains unsettled. Lawmakers still have major choices to make about the programs, research, workforce and public health systems communities rely on. During the House and Senate work periods, many members return to the states and districts they represent. For public health advocates, August is not a pause in the policy process. It is a chance to bring a clear request to the people who will pass a vote. 

July 31, 2026

New GHAI Public Comment Urges CMS to Protect Medicaid Coverage for People with Substance Use Disorders

The Centers for Medicare & Medicaid Services (CMS) issued an interim final rule explaining how states must implement this new community engagement requirement. The requirement is the policy created by Congress. The CMS rule provides the framework states will use to determine who is affected, identify and verify exemptions and decide whether someone can enroll in or keep Medicaid coverage. The Global Health Advocacy Incubator’s (GHAI) Overdose Prevention Initiative submitted comments urging CMS to strengthen protections for people with substance use disorders.